Publications by authors named "Claas Reimer"

Claim this Profile
T
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis.
Lennart Lenk, Irène Baccelli, Anna Laqua, Julia Heymann, Claas Reimer

Blood· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis